This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignee: Cancer Research Technology Limited. Active years: 2006-2007.
Location History:
- Reigate, GB (2006 - 2007)
- Surrey, GB (2007)
Company Filing History:
Years Active: 2006-2007
Title: Lloyd Royston Kelland: Innovator in Therapeutic Compounds
Introduction
Lloyd Royston Kelland is a notable inventor based in Reigate, GB. He has made significant contributions to the field of therapeutic compounds, particularly in the development of acridone and acridine compounds. With a total of 4 patents to his name, Kelland's work focuses on innovative solutions for treating proliferative conditions, including cancer.
Latest Patents
Kelland's latest patents revolve around therapeutic acridone and acridine compounds. These compounds are designed to inhibit telomerase and regulate cell proliferation. The inventions include specific formulas where either K is a 9-substituent or K is a group of the formula —N(R)Q. These compounds are also associated with pharmaceutical compositions that can be used both in vitro and in vivo for treating various proliferative conditions.
Career Highlights
Kelland is associated with Cancer Research Technology Limited, where he continues to advance his research and development efforts. His work has been instrumental in creating compounds that have the potential to significantly impact cancer treatment.
Collaborations
Some of his notable coworkers include Sharon Michele Gowan and Martin Anthony Read. Their collaborative efforts contribute to the innovative research being conducted at Cancer Research Technology Limited.
Conclusion
Lloyd Royston Kelland's contributions to the field of therapeutic compounds highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment and other proliferative conditions.